Because the early life of a compound is dependent on the data and analysis derived from Phase I Studies, it is imperative that these trials are managed and conducted with the highest quality and care. Therefore, well-honed project management skills that can address the unique issues associated with Phase I Studies are needed. This web seminar will examine the importance of Phase I Studies in drug development, the issues commonly associated with conducting a Phase I Study from a sponsor perspective and provide project management best practices specific to overseeing a Phase I Study.
- Define Phase I Studies
- Examine the importance of Phase I data in clinical development
- Review general considerations for a Phase I Study
- Describe the attributes of an effective Phase I Unit
- List project management best practices specific for Phase I clinical trials
- Project Managers
- Study Directors
- Site Monitors
Erica Elefant, R.N., B.S.N., M.S.W.
Click here for complete trainer biographies
$595
Includes up to 20 participants at one site. All participants (up to 20) are eligible for “Certificates of Attendance,” and accreditation, provided that accreditation requirements are met. For groups larger than 20 or for additional sites, please call 1-800-856-2556 for pricing.
Barnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants will receive 1.5 hours (0.15 CEUs) of continuing education credit for full participation, including the completion of a pre-test, post-test, and program evaluation. Barnett International will mail ACPE statements within three weeks of program completion. ACPE#: 778-000-09-061-L04-P. Released: 6/10.
Hold this course at your company! For more information, contact Naila Ganatra at (215) 413-2471.